Sanomedics to Showcase the Caregiver® at National Teaching Institute & Critical Care Exposition

MIAMI, May 12, 2015 /PRNewswire/ -- Sanomedics, Inc. (OTC: SIMH) ("Sanomedics" or the "Company"), an international medical technology company focused on developing, manufacturing, and acquiring cutting-edge technology, products and services, announced that it will be exhibiting at the National Teaching Institute & Critical Care Exposition (NTI) from May 19-21, 2015 in San Diego, CA.

NTI is the premier conference and exposition for high acuity and critical care nurses in the United States. This year, NTI will attract over 6,000 nurses, allowing them to take home new evidence-based knowledge to make an impact in the workplace and in patient care. The conference includes over 300 live sessions and more than 300 exhibitors showcasing the latest in technology and practice innovations. NTI will take place at the San Diego Convention Center.

The Sanomedics' booth #914 will provide attendees with an opportunity to learn about Sanomedics and the Caregiver®  the world's first non-contact device with TouchFree™ technology developed by the team that invented tympanic thermometry. The Caregiver® is a clinical-grade infrared thermometer for measurement of forehead temperature in adults, children, and infants without contact. It is designed for use in a wide variation of medical settings and can also deliver ambient/skin surface temperatures with the flick of a switch.

"There is a rising incidence of fever based illnesses, and nurses need the right tool to help them effectively identify symptoms; the Caregiver® thermometer is the device which offers instant, accurate temperatures and easy-to-use features which help nurses do their jobs more efficiently," said Ron Benincasa, Vice President of Marketing & Sales at Sanomedics.  "NTI is the leading critical care and high acuity nursing conference and exposition and provides Sanomedics and the Caregiver® the perfect platform to educate nurses about the benefits of non-contact thermometry."

About Sanomedics, Inc.
Sanomedics, Inc. (OTC: SIMH) is an international medical technology company focused on developing, manufacturing, and acquiring cutting-edge technology, products and services. The Company operates mainly through its subsidiary, Thermomedics, which is dedicated to engineering, marketing and selling the Caregiver TouchFree™ Infrared thermometer. The Caregiver non-contact thermometer is FDA-cleared in the United States for clinical use by medical professionals. The Caregiver provides an accurate and expedited temperature reading without direct contact between patient and medical professional. Sanomedics has established an extensive distribution network with several leading healthcare supply chain providers to increase adoption of the Caregiver device within the medical community worldwide.

Forward Looking Statements
Statements in this press release regarding Sanomedics that are not historical facts are forward- looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements, including, but not limited to, financial guidance are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not directly or exclusively relate to historical facts. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "estimates," "projects," "forecasts," "predicts," "potential," or the negative of those terms, and similar expressions and comparable terminology. These include, but are not limited to, statements relating to future events or our future financial and operating results, plans, objectives, expectations and intentions. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these expectations may not be achieved. Forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to known and unknown risks, uncertainties and other factors outside of our control that could cause our actual results, performance or achievement to differ materially from those expressed or implied by these forward-looking statements.

These forward-looking statements represent our estimates and assumptions only as of the date of this release and, except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this release. Given these uncertainties, you should not place undue reliance on these forward-looking statements and should consider various factors, including the risks described, among other places, in our most recent Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q, as well as any amendments thereto, filed with the SEC.

Investor Contacts: 
Phil Carlson / Elizabeth Barker
KCSA Strategic Communications
212-896-1233 / 212-896-1203
[email protected] / [email protected] 

Media Contacts:
Chloe Font / Andrew Herweg
KCSA Strategic Communications
212-896-1287 / 212-896-1273
[email protected] / [email protected]

SOURCE Sanomedics, Inc.

Related Links

http://www.sanomedics.com